Table 5 Percentage of ICON Maxx and Iconet CTN meeting WHO efficacy criteria by survey round
Survey (month) | ICON Maxx | lambda-cyhalothrin CTN | ||||
|---|---|---|---|---|---|---|
Cone bioassays | Tunnel tests | Cone and tunnel tests combined | Cone bioassays | Tunnel tests | Cone and tunnel tests combined | |
0 | 100 (30/30) | – | 100 (30/30) | 100 (30/30) | – | 100 (30/30) |
6 | 96.7 (29/30) | 100 (1/1) | 100 (30/30) | 73.3 (22/30) | 25 (2/8) | 80 (24/30) |
12 | 93.3 (28/30) | 50.0 (1/2) | 96.7 (29/30) | 56.7 (17/30) | 23 (3/13) | 66.7 (20/30) |
18 | 70.0 (21/30) | 88.9 (8/9) | 96.7 (29/30) | – | – | – |
24 | 70.0 (21/30) | 66.7 (6/9) | 90.0 (27/30) | – | – | – |
30 | 33.3 (10/30) | 80.0 (16/20) | 86.7 (26/30) | – | – | – |
36 | 26.0 (13/50) | 37.0 (32/37) | 90.0 (45/50) | – | – | – |